Financial reports
10-K
2023 FY
Annual report
1 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
28 Feb 22
Current reports
8-K
Other Events
28 Feb 24
8-K
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
26 Feb 24
8-K
Other Events
16 Jan 24
8-K
Other Events
5 Jan 24
8-K
Other Events
28 Dec 23
8-K
Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors
21 Dec 23
8-K
Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
7 Nov 23
8-K
Other Events
30 Oct 23
8-K
Regulation FD Disclosure
12 Sep 23
8-K
Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
7 Aug 23
Registration and prospectus
SC TO-I/A
Issuer tender offer statement (amended)
22 Nov 22
SC TO-I/A
Issuer tender offer statement (amended)
18 Nov 22
SC TO-I/A
Issuer tender offer statement (amended)
14 Nov 22
SC TO-I/A
Issuer tender offer statement (amended)
9 Nov 22
SC TO-I/A
Issuer tender offer statement (amended)
7 Nov 22
SC TO-I
Issuer tender offer statement
28 Sep 22
SC TO-C
Information about tender offer
19 Sep 22
SC TO-I/A
Issuer tender offer statement (amended)
25 Aug 22
SC TO-I/A
Issuer tender offer statement (amended)
8 Aug 22
SC TO-I/A
Issuer tender offer statement (amended)
5 Aug 22
Proxies
DEF 14A
Definitive proxy
5 Apr 24
DEFA14A
Additional proxy soliciting materials
21 Dec 23
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEF 14A
Definitive proxy
28 Mar 23
PRE 14A
Preliminary proxy
17 Mar 23
DEFA14A
Additional proxy soliciting materials
28 Feb 23
DEFA14A
Additional proxy soliciting materials
28 Feb 23
DEF 14A
Definitive proxy
25 Mar 22
DEF 14A
Definitive proxy
22 Mar 21
Other
CORRESP
Correspondence with SEC
6 Oct 22
UPLOAD
Letter from SEC
29 Sep 22
CORRESP
Correspondence with SEC
5 Aug 22
UPLOAD
Letter from SEC
1 Aug 22
CT ORDER
Confidential treatment order
9 Aug 19
CT ORDER
Confidential treatment order
20 Dec 18
UPLOAD
Letter from SEC
24 Oct 18
CORRESP
Correspondence with SEC
3 Aug 18
UPLOAD
Letter from SEC
23 Jul 18
CORRESP
Correspondence with SEC
28 Jun 18